A 59-year-old woman was referred to our hospital for evaluation of chest pain and dyspnea. On transthoracic echocardiography, a left atrial mass suggestive of myxoma was detected ( Figure 1A) . To evaluate the vascularization of the left atrial mass, venous infusion (1 mL/min) of a thirdgeneration echocardiographic contrast agent (Sono Vue, Bracco, Italy) was subsequently combined with a new contrast-specific imaging technique ("power modulation imaging," Phillips Medical Systems, Eindhoven, the Netherlands). With conventional diagnostic ultrasound, gas-filled microbubbles, the main components of echocardiographic contrast agents, are destroyed by high acoustic power (mechanical index usually Ͼ0.8) and tissue perfusion cannot be continuously imaged. Power modulation imaging, on the other hand, allows for marked reduction of transmission power (mechanical index 0.1 in the present study), resulting in tissue microbubble concentrations unequivocally above the detection threshold of the imaging system. Therefore, tissue perfusion can be continuously visualized with this technique. Figure 1B depicts the appearance of the contrast agent in the cavity of the left ventricle after initiation of the contrast infusion. A few frames later ( Figure 1C) , the left ventricular myocardium and the left atrial mass were opacified at the same time. Preoperative coronary angiography demonstrated normal coronary arteries and vascular supply of the left atrial mass originating from the right coronary artery (Figure 2) . The patient underwent surgery, and histopathologic evaluation confirmed the initial suspicion of myxoma.
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